GrowBLOX Sciences, Inc. Majority Controlled Applicant, GB Sciences Nevada, Submits Three Medical Marijuana Establishment Filings for Unincorporated Clark County - 8NEWS - WRIC | News Where You Live

GrowBLOX Sciences, Inc. Majority Controlled Applicant, GB Sciences Nevada, Submits Three Medical Marijuana Establishment Filings for Unincorporated Clark County

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact

SOURCE GrowBLOX Sciences, Inc.

LAS VEGAS, May 6, 2014 /PRNewswire/ -- GrowBLOX Sciences, Inc. (OTCQB: GBLX) announces today that its majority controlled Nevada applicant, GB Sciences Nevada, LLC has submitted three medical marijuana establishment permit applications (two Dispensaries and one Cultivation Facility) in Clark County, Nevada.  Clark County – which accepted applications from April 16 through May 2 – is the first local jurisdiction in Nevada to begin accepting applications for medical marijuana businesses and plans to grant 10 dispensary licenses and a minimum of 40 cultivation licenses. 

GrowBLOX Sciences CEO Craig Ellins stated, "I believe our proprietary growing technology will present a competitive edge among other applicants, significantly impacting the emerging medical marijuana industry within the state. By filing the applications for licensing in Nevada, we seek to meet the needs of the local patient community with superior standards in product quality and safety."

About GrowBLOX Sciences, Inc.
GrowBLOX Sciences, Inc., is a research and biotechnical company that has developed proprietary indoor growing chambers specifically designed for medical cannabis cultivation.  The GrowBLOX chamber allows for completely controlled growing conditions, ensuring the manufacture of a consistent, toxin-free, natural and medicinal-grade product.  The Company believes that the advantages of a controlled environment over traditional outdoor or greenhouse growing, will empower the public, nutraceutical and pharmaceutical industries to embrace cannabis as an effective treatment for a myriad of serious medical conditions.

Forward-Looking Statements
Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements are inherently unreliable and actual results may differ materially.  Examples of forward-looking statements in this news release include statements regarding the payment of dividends, marketing and distribution plans, development activities and anticipated operating results.  Factors which could cause actual results to differ materially from these forward-looking statements include such factors as the Company's ability to accomplish its business initiatives, significant fluctuations in marketing expenses and ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission.  The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Craig Ellins
CEO, GrowBLOX Sciences, Inc.
+1-844-843-BLOX ext. 01

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow

301 Arboretum Place, Richmond
VA, 23236

Telephone: 804.330.8888
Fax: 804.330.8881

Can't find something?
Powered by WorldNow
All content © Copyright 2000 - 2014 Media General Communications Holdings, LLC. A Media General Company.